ESH Video

5th Translational Research Conference: Multiple Myeloma

5th Translational Research Conference: Multiple Myeloma
October 08 - October 11, 2020 - ONLINE CONFERENCE,
Chairs : Kenneth C. Anderson, Maria Victoria Mateos, Philippe Moreau

Information

CONFERENCE UPDATE: novel coronavirus (COVID-19)

ESH 5th Translational Conference:
Multiple Myeloma: MOVING ONLINE

October 8-11, 2020
Chairs: Kenneth C. Anderson, Maria-Victoria Mateos, Philippe Moreau

 

ABOUT THE E-CONFERENCE:

In view of continuing COVID-19 related challenges and uncertainties, ESH has decided to hold this year’s Translational Research Conference on Multiple Myeloma as a virtual event. Please note that it will begin one day earlier than initially planned, extending from October 8-11, 2020.

An outstanding faculty of distinguished global experts will present the most recent advances and new perspectives in the field of Multiple Myeloma and plasma disorders, from pathophysiology to diagnosis and therapy, including current challenges and new perspectives.

The plenary E-Conference programme is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for scientific discussion and interaction.

Registered participants will further benefit from opportunities for informal scientific interaction with the world’s leading experts in the field during closed Meet the Expert sessions and E-Mentored Posters Walks.

Participants will be joining us from all over the world and from different time zones. To make sure that everyone has access to the full scientific programme at a convenient hour, registration will allow participants to join both the LIVE PROGRAMME  and the PROGRAMME ON DEMAND.

– The “Live Programme” is to be found on programme page. It will be streamed live CEST time, as indicated. It will include lectures, roundtable discussions, Meet the Expert sessions, interactive panel discussions, voting and Q&A periods, and Mentored Poster Walks. It will also include some pre-recorded lectures that will be streamed live, followed by their corresponding fully live Q&A period.

– The “Programme on Demand” available as of September 29th, 2020, will initially include the pre-recorded components of the scientific programme. It will be progressively enriched by the meeting’s live, interactive components which will be recorded real time during the meeting.

The Virtual platform will remain open from September 29 until October 21, 2020 so that participants can view and review the programme’s full scientific content at times convenient to them.

We have selected a platform with the technical capacity and environment which we feel responds to ESH objectives in terms of learning, scientific interaction and conviviality.

We hope that you will be interested in joining us for this ESH E-Conference on Multiple Myeloma,

In the meantime Stay Safe!
The ESH Team

 


 

ESH 5th Translational Conference:
Multiple Myeloma
(Initially October 9-11, 2020 – Mandelieu-La Napoule, France)
Chairs: Kenneth C. Anderson, Maria-Victoria Mateos, Philippe Moreau

 

This meeting aims to bring to the forefront the latest breakthroughs in multiple myeloma and plasma cell disorders. The unique format of the programme provides ample time for discussion following each lecture and, at the same time, the program will provide a unique opportunity for world leaders in the ­ field of plasma cell disorders to debate vital and contentious issues in Myeloma. This thought-provoking academic dialogue will address the most challenging current biology, clinical and therapeutic questions.

This conference intends to promote informal interaction and ample discussion between scientists and clinicians working in the field. Scientific presentations by international leaders will provide the current status and a perspective of these exciting developments. Results from both basic and clinical research will be presented.

Posters and Brief Oral Communications:

Registered participants are invited to submit their Biology and Clinical abstracts. Selected abstracts will be presented as brief oral communications or posters.

 
This meeting will be valuable to you if you are looking for:

  • A cutting-edge scientific programme – from basic science to clinical and therapeutic applications and perspectives.
  • An emphasis on in-depth scientific discussion
  • Opportunities for informal face-to-face scientific interaction with global authorities in the field.

The meeting will be of interest to:

  • Senior biologists and clinicians, including experts in the field (MD, PhD, MD-PhD)
  • Junior scientists and clinicians (MD, PhD)
  • PhD candidates and clinical residents still in-training

 
Learning Objectives:

  • Update on the pathophysiology of myeloma and how the disease is evolving from MGUS and SMM.
  • Update on the diagnostic criteria and the use of new assessments in the diagnostic process
  • Treatment of young myeloma patients

  • Treatment of elderly and frail myeloma patients
  • Optimal sequencing at the relapse
  • To know what is the role of new immunotherapic approaches and how will they fit in the landscape
  • Role of novel drugs under development

  • Latest updates in other plasma cell disorders beyond myeloma

 
Topics:

  • Smoldering Myeloma
  • Diagnosis of Multiple Myeloma
  • Frontline therapy in patients not eligible for autologous stem cell transplantation
  • Frontline therapy in patients eligible for autologous stem cell transplantation
  • MRD and the microenvironment
  • Relapsed Multiple Myeloma
  • The future: recent clinical trials in relapse
  • Data management issues
  • Plasma cell disorders

 
The programme will include:

  • Plenary Sessions
  • Simultaneous Meet the Experts Sessions
  • Poster Walks
  • Brief Oral Communications
  • Controversial Debates
  • Ample time for in-depth discussion

 

Abstract submission

Abstract submission is closed

 

Abstract Guidelines:

  • Your abstract should be structured (eg Objectives, Methods, Results, Conclusions) 
  • Maximum number of words: 400 
  • You abstract will be submitted to the peer review procedure. 

 

Symposia

Friday, October 9th from 13:20 to 14:20:
What have we learnt about the use of cellular therapies in multiple myeloma ?
Speakers
: Maria-Victoria Mateos (Salamanca), Deepu Madduri (New York)
This symposium is organised and supported by Janssen Pharmaceutical Companies of Johnson & Johnson in EMEA

Saturday, October 10th from 9:30 to 10:30 am:
CAR T cell therapy: A new strategy in relapsed/refractory multiple myeloma
Chair: Maria-Victoria Mateos (Salamanca)
Speakers: Michel Delforge (Leuven), Xavier Leleu (Poitiers), Maria-Victoria Mateos (Salamanca)
This symposium is organized and funded by Bristol Myers Squibb

Saturday, October 10th from 12:30 to 13:30 pm:
Multiple Myeloma: Toward the Implementation of Measurable Residual Disease (MRD) in Clinical Practice 
Speakers:
Maria-Victoria Mateos (Salamanca), Jeffrey Wolf (San Francisco)
This symposium is organised and funded by Adaptive Biotechnologies

Sunday, October 11th from 10:15 to 11:15 am:
From bench to bedside: a new dawn for agents targeting b-cell maturation antigen (bcma) in relapsed/refractory multiple myeloma
Speakers: Francesca Gay (Turin), Philippe Moreau (Nantes), Paula Rodriguez (Pamplona), Katja Weisel (Hamburg)
This symposium is organised and funded by GSK

 

Accommodation

N/A

Venue

Conference moving online, click here to access and visist the the E-Conference platform.

Corporate partners

With the support of*

 

Premium Conference Partner

 

**********

 

 

Diamond Conference Partner

 

 **********

 

         

 

Ruby Conference Partners

 

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.

Scholarships

N/A

Workshop

Educational Grants

ESH gratefully acknowledges

Celgene-BMS logo

for providing a Medical Education Grant

towards this independent programme.

Registration

The registration fee for the “5th Translational Research Conference: Multiple Myeloma” E-CONFERENCE is:
– Fully trained: 80€
– In-training: 50€
– Allied Health Professionals: 50€
– Corporate: 150€

A proof will be requested to confirm your status.

This fee includes:
Access to the on demand programme from September 29 till October 21, 2020
Access to the live programme
Access to the Conference E-Book from October 8 till October 21, 2020
Access to the E-Poster Area from September 29 till October 21, 2020
Access to the E-Poster Walk session

Your access to the conference will be definitively confirmed upon receipt of your fee.

 

IMPORTANT NOTE:
MEET THE EXPERT SESSIONS registration will open closer to the E-CONFERENCE (extra fee of 20€ per session). 

How to proceed :
Please make sure that your Internet browser (Firefox, Safari, Google Chrome…) is up-to-date. Using an old version may prevent you from visualising the full website content.

Cancellation policy of registration fee :
In case of cancellation, up until 3 months prior to the beginning of the meeting, your registration fee will be reimbursed in full (less bank charges). If the cancellation is notified after this delay your registration to the meeting will not be reimbursed. 

Register Here